THERAPY OF THE MALIGNANT CARCINOID SYNDROME.
D018926:Anti-Allergic Agents; D000959:Antihypertensive Agents; D003520:Cyclophosphamide; D005472:Fluorouracil; D006634:Histamine H1 Antagonists; D006801:Humans; D008303:Malignant Carcinoid Syndrome; D008727:Methotrexate; D009369:Neoplasms / Q000532:radiotherapy* / Q000628:therapy*; D009588:Nitrogen Mustard Compounds; D012701:Serotonin; D017367:Selective Serotonin Reuptake Inhibitors; D013256:Steroids; D013514:Surgical Procedures, Operative
D018926:Anti-Allergic Agents; D000959:Antihypertensive Agents; D003520:Cyclophosphamide; D005472:Fluorouracil; D006634:Histamine H1 Antagonists; D008727:Methotrexate; D009588:Nitrogen Mustard Compounds; D012701:Serotonin; D017367:Selective Serotonin Reuptake Inhibitors; D013256:Steroids
ANTIHISTAMINICS; ANTIHYPERTENSIVE AGENTS; CYCLOPHOSPHAMIDE; FLUOROURACIL; MALIGNANT CARCINOID SYNDROME; METHOTREXATE; NEOPLASM RADIOTHERAPY; NEOPLASM THERAPY; NITROGEN MUSTARD COMPOUNDS; REVIEW; SEROTONIN INHIBITORS; STEROIDS; SURGERY, OPERATIVE